Publications | US Medical Innovations

The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer

by Admin-USMI | Jul 20, 2023 | Cold Plasma, Publications

Takoma Park, MDRead...

Canady Cold Helios Plasma Reduces Soft Tissue Sarcoma Viability by Inhibiting Proliferation, Disrupting Cell Cycle, and Inducing Apoptosis: A Preliminary Report

by Admin-USMI | Aug 4, 2022 | Cold Plasma, Publications

Takoma Park, MDRead...

The Granger Causal Effects of Canady Helios Cold Plasma on the Inhibition of Breast Cancer Cell Proliferation

by Admin-USMI | May 19, 2022 | Cold Plasma, General, Publications

Takoma Park, MDRead...

JCRI DISCOVERS REGULATORY GENE BCL2A1 FOR TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER

by Admin-USMI | Mar 15, 2022 | Cold Plasma, General, Publications

Saravana R.K. Murthy, Taisen Zhuang, Xiaoqian Cheng, Lawan Ly, Olivia Jones, Giacomo Basadonna, Michael Keidar and Jerome Canady Read Full...

Canady Helios Cold Plasma Induces Breast Cancer Cell Death by Oxidation of Histone mRNA

by Admin-USMI | Sep 15, 2021 | Publications

By Xiaoqian Cheng, Saravana R. K. Murthy, Taisen Zhuang, Lawan Ly, Olivia Jones, Giacomo Basadonna, Michael Keidar, Yasmine Kanaan, and Jerome Canady Read Full...

The Synergistic Effect of Canady Helios Cold Atmospheric Plasma and a FOLFIRINOX Regimen for the treatment of Cholangiocarcinoma In Vitro

by PVA Editor | May 12, 2021 | Cold Plasma, Publications

The Synergistic Effect of Canady Helios Cold Atmospheric Plasma and a FOLFIRINOX Regimen for the treatment of Cholangiocarcinoma In Vitro By Olivia Jones, Xiaoqian Cheng, Saravana R. K. Murthy, Lawan Ly, Taisen Zhuang, Giacomo Basadonna, Michael Keidar, & Jerome...